EBM Focus

Free CDS tools exist because of ad revenue, which is worth it for pharmaceutical companies for the high-value prospect of clinical influence at the moment of care. Dr. Z explains in his latest article.

Part 1 of this series established clinical context and lived experience of Tourette Syndrome. Part 2 will explore therapeutic possibilities and the role of public education. (3 minute read)

Learn how evidence-based clinical integrations work and the questions to ask potential partners before deploying any point-of-care integration.

Considerations from a primary care perspective about how to apply the ACC/AHA dyslipidemia guideline recommendations in everyday clinical practice.

As Part 1 of this series, this article establishes clinical context and lived experience of Tourette Syndrome. Part 2 will explore the promise of research and the role of awareness. (3 minute read)

Busy clinicians are constantly navigating life-changing conversations, often under time pressure and without all the information they need. Dyna AI is the solution.

ACC/AHA lipid guidelines now emphasize lifetime ASCVD risk management, with updated recommendations on who to screen and when, how to use the PREVENT score, treatment thresholds, LDL‑C goals, and flexible use of nonstatin therapies.

Periodic paralysis is a rare inherited muscle disorder causing sudden weakness or paralysis, often on waking. This article explains types, diagnosis, triggers, and management strategies for patients and clinicians. [4-minute read]

New AI in healthcare research explores how clinical decision support (CDS) AI reclaims clinician time and earns patient trust. Get the newest AI-CDS stats.

In this latest edition, Dr. Z discusses how appearance can impact trust and how the team at DynaMed emphasizes transparency to instill confidence in their clinical decision support tools.